The lung in paracoccidioidomycosis: new insights into old problems

OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis patients was performed using high resolution computed tomography, pulmonary function tests, ergospirometry, the six-minute walk test and health-related quality of life questionnaires. RESULTS: Radiological abnormalities were present in 98% of cases, the most frequent of which were architectural distortion (90%), reticulate and septal thickening (88%), centrilobular and paraseptal emphysema (84%) and parenchymal bands (74%). Patients typically presented with a mild obstructive disorder and a mild reduction in diffusion capacity with preserved exercise capacity, including VO2max and six-minute walking distance. Patient evaluation with the Saint-George Respiratory Questionnaire showed low impairment in the health-related quality of life, and the Medical Research Council questionnaire indicated a low dyspnea index. There were, however, patients with significant oxygen desaturation upon exercise that was associated with respiratory distress compared with the non-desaturated patients. The initial counterimmunoelectrophoresis of these patients was higher and lung emphysema was more prominent; however, there were no differences in the interstitial fibrotic tomographic abnormalities, tobacco exposure, functional responses, exercise capacity or quality of life. CONCLUSIONS: Inactive, chronic paracoccidioidomycosis patients show persistent and disseminated radiological abnormalities by high resolution computed tomography, short impairments in pulmonary function and low impacts on aerobic capacity and quality of life. However, there was a subset of individuals whose functional impairment was more severe. These patients present with higher initial serology and more severe emphysema, stressing the importance of adequate treatment associated with tobacco exposure cessation.

[1]  M. Godoy,et al.  Reversed halo sign: high-resolution CT scan findings in 79 patients. , 2012, Chest.

[2]  A. A. Machado,et al.  Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. , 2011, The American journal of tropical medicine and hygiene.

[3]  C. Pereira,et al.  Teste de caminhada de seis minutos: valores de referência para adultos saudáveis no Brasil , 2011 .

[4]  Á. Restrepo,et al.  Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. , 2011, Pulmonary pharmacology & therapeutics.

[5]  G. Washko,et al.  Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD , 2010, European Respiratory Journal.

[6]  J. Prolla,et al.  Association between paracoccidioidomycosis and cancer. , 2010, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[7]  Fabio Pitta,et al.  Validação do Modified Pulmonary Functional Status and Dyspnea Questionnaire e da escala do Medical Research Council para o uso em pacientes com doença pulmonar obstrutiva crônica no Brasil , 2008 .

[8]  G. Benard.  An overview of the immunopathology of human paracoccidioidomycosis , 2008, Mycopathologia.

[9]  Z. P. Camargo.  Serology of paracoccidioidomycosis , 2008, Mycopathologia.

[10]  V. B. Richini-Pereira,et al.  Ecological study of Paracoccidioides brasiliensis in soil: growth ability, conidia production and molecular detection , 2007, BMC Microbiology.

[11]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[12]  C. Pereira,et al.  New reference values for forced spirometry in white adults in Brazil. , 2007, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[13]  E. Gasparetto,et al.  High-resolution CT findings of 77 patients with untreated pulmonary paracoccidioidomycosis. , 2006, AJR. American journal of roentgenology.

[14]  C. Fontes,et al.  Drugs for treating paracoccidioidomycosis. , 2006, The Cochrane database of systematic reviews.

[15]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[16]  Á. Restrepo,et al.  Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Poulain,et al.  6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. , 2003, Chest.

[18]  B. Wanke,et al.  Paracoccidioidomycosis mortality in Brazil (1980-1995). , 2002, Cadernos de saude publica.

[19]  M. Ferrer,et al.  Interpretation of quality of life scores from the St George's Respiratory Questionnaire , 2002, European Respiratory Journal.

[20]  J. R. Jardim,et al.  Validacao do questionario do Hospital Saint George na doenca respiratoria (SGRQ) em pacientes portadores de doenca pulmonar obstrutiva cronica no Brasil , 2000 .

[21]  B. Whipp,et al.  Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. , 1999, The European respiratory journal.

[22]  S. Nouér,et al.  Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. , 1999, The American journal of tropical medicine and hygiene.

[23]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[24]  N. Müller,et al.  Chronic pulmonary paracoccidioidomycosis (South American blastomycosis): high-resolution CT findings in 41 patients. , 1999, AJR. American journal of roentgenology.

[25]  J. Neder,et al.  Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[26]  J. Neder,et al.  Reference values for lung function tests. I. Static volumes. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  C. Carvalho,et al.  Hyperoxia and lung disease. , 1998, Current opinion in pulmonary medicine.

[28]  R. Crapo.  Carbon Monoxide Diffusing Capacity (Transfer Factor) , 1998 .

[29]  E. Burger,et al.  Immunity to Paracoccidioides brasiliensis infection. , 1998, Research in immunology.

[30]  S. Restrepo,et al.  Development of pulmonary fibrosis in mice during infection with Paracoccidioides brasiliensis conidia. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[31]  C. R. Padovani,et al.  Paracoccidioidomicose: estudo radiológico e pulmonar de 58 casos , 1991 .

[32]  A. J. M. Cataneo,et al.  Função pulmonar na evolução de 35 doentes com paracoccidioidomicose , 1986 .

[33]  R. Tuder,et al.  Pathology of the human pulmonary paracoccidioidomycosis , 1985, Mycopathologia.

[34]  W. Dismukes,et al.  Current therapy of pulmonary and disseminated fungal diseases. , 1983, Chest.

[35]  B. Wanke,et al.  Pulmonary function in paracoccidioidomycosis (South American blastomycosis). An analysis of the obstructive defect. , 1983, Chest.

[36]  B. Wanke,et al.  Pulmonary localization of paracoccidioidomycosis: lung function studies before and after treatment. , 1983, Revista do Instituto de Medicina Tropical de Sao Paulo.

[37]  L. Nery,et al.  [Pulmonary function in paracoccidioidomycosis (South American blastomycosis)]. , 1979, Revista do Instituto de Medicina Tropical de Sao Paulo.

[38]  A. Lemle,et al.  Lung function studies in pulmonary South American blastomycosis. Correlation with clinical and roentgenologic findings. , 1970, The American journal of medicine.

[39]  S. Rounds,et al.  Combined pulmonary fibrosis and emphysema syndrome: a review. , 2012, Chest.

[40]  E. Marchiori,et al.  Thoracic paracoccidioidomycosis: radiographic and CT findings. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[41]  D. Capone,et al.  Paracoccidioidomycosis: high-resolution computed tomography-pathologic correlation. , 2011, European journal of radiology.

[42]  C. Pereira,et al.  Six-minute walk test: reference values for healthy adults in Brazil. , 2011, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[43]  C. Agudelo,et al.  Pulmonary paracoccidioidomycosis. , 2008, Seminars in respiratory and critical care medicine.

[44]  F. Pitta,et al.  Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[45]  Zoilo Pires de Camargo.  Serology of paracoccidioidomycosis. , 2008, Mycopathologia.

[46]  Maria Aparecida Shikanai-Yasuda,et al.  [Guidelines in paracoccidioidomycosis]. , 2006, Revista da Sociedade Brasileira de Medicina Tropical.

[47]  E. Zandonade,et al.  Associação entre tabagismo e paracoccidioidomicose: um estudo de caso-controle no Estado do Espírito Santo, Brasil , 2003 .

[48]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[49]  G. Benard,et al.  Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. , 2002, Medical mycology.

[50]  S. A. Palácios,et al.  Evaluation of tests for antibody response in the follow-up of patients with acute and chronic forms of paracoccidioidomycosis. , 2000, Journal of medical microbiology.

[51]  J. Neder,et al.  Reference values for lung function tests. I. Static volumes. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.